Advanced mechanistic studies of GSK1265744, a new HIV integrase inhibitor (INI) dosed by oral administration or long-acting parenteral injection

被引：0
|
作者：
Yoshinaga, T. [1 ]
Kobayashi, M. [1 ]
Seki, T. [1 ]
Wakasa-Morimoto, C. [1 ]
Kawasuji, T. [1 ]
Taishi, T. [1 ]
Sato, A. [1 ]
Fujiwara, T. [1 ]
Johns, B. [2 ]
Underwood, M. [2 ]
机构：
[1] Shionogi & Co Ltd, Osaka, Japan
[2] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
ANTIVIRAL THERAPY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 7 条
  • [1] Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection
    Yoshinaga, Tomokazu
    Kobayashi, Masanori
    Seki, Takahiro
    Miki, Shigeru
    Wakasa-Morimoto, Chiaki
    Suyama-Kagitani, Akemi
    Kawauchi-Miki, Shinobu
    Taishi, Teruhiko
    Kawasuji, Takashi
    Johns, Brian A.
    Underwood, Mark R.
    Garvey, Edward P.
    Sato, Akihiko
    Fujiwara, Tamio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 397 - 406
  • [2] HIV PrEP Dose Rationale for Cabotegravir (GSK1265744) Long-acting Injectable Nanosuspension
    Spreen, Bill
    Rinehart, Alex
    Smith, Kimberly
    Margolis, David
    Ford, Susan
    Piscitelli, Steve
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A12 - A12
  • [3] GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects
    Spreen, William
    Ford, Susan L.
    Chen, Shuguang
    Wilfret, David
    Margolis, David
    Gould, Elizabeth
    Piscitelli, Stephen
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (05) : 481 - 486
  • [4] Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
    Thoueille, Paul
    Saldanha, Susana Alves
    Schaller, Fabian
    Choong, Eva
    Veuve, Francois
    Munting, Aline
    Cavassini, Matthias
    Braun, Dominique
    Gunthard, Huldrych F.
    Duran Ramirez, Jessy J.
    Surial, Bernard
    Furrer, Hansjakob
    Rauch, Andri
    Ustero, Pilar
    Calmy, Alexandra
    Stoeckle, Marcel
    Di Benedetto, Caroline
    Bernasconi, Enos
    Schmid, Patrick
    Marzolini, Catia
    Girardin, Francois R.
    Buclin, Thierry
    Decosterd, Laurent A.
    Guidi, Monia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1450 - 1459
  • [5] Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
    Thoueille, Paul
    Saldanha, Susana Alves
    Schaller, Fabian
    Choong, Eva
    Veuve, Francois
    Munting, Aline
    Cavassini, Matthias
    Braun, Dominique
    Gunthard, Huldrych F.
    Ramirez, Jessy J. Duran
    Surial, Bernard
    Furrer, Hansjakob
    Rauch, Andri
    Ustero, Pilar
    Calmy, Alexandra
    Stockle, Marcel
    Di Benedetto, Caroline
    Bernasconi, Enos
    Schmid, Patrick
    Marzolini, Catia
    Girardin, Francois R.
    Buclin, Thierry
    Decosterd, Laurent A.
    Guidi, Monia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] PHASE-I STUDY OF Y-20811, A NEW LONG-ACTING THROMBOXANE SYNTHETASE INHIBITOR BY ORAL-ADMINISTRATION
    NAKASHIMA, M
    UEMATSU, T
    TAKIGUCHI, Y
    MIZUNO, A
    KANAMARU, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (06): : 568 - 576
  • [7] Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjects
    Han, Kelong
    Baker, Mark
    Lovern, Mark
    Paul, Prokash
    Xiong, Yuan
    Patel, Parul
    Moore, Katy P.
    Seal, Ciara S.
    Cutrell, Amy G.
    D'Amico, Ronald D.
    Benn, Paul D.
    Landovitz, Raphael J.
    Marzinke, Mark A.
    Spreen, William R.
    Ford, Susan L.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (10) : 4607 - 4622
1